Exploring the mechanisms of renoprotection against progressive glomerulosclerosis

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 87, Issue 3, 2011, Pages 81-90

  Oite, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Chronic kidney disease; Glomerular hemodynamics; In vivo imaging; Progressive glomerululosclerosis; Renoprotection

Indexed keywords

ANIMAL; DISEASE COURSE; DRUG EFFECT; EXTRACELLULAR SPACE; GLOMERULONEPHRITIS; HUMAN; KIDNEY; MESANGIUM CELL; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR SPACE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MESANGIAL CELLS; RISK FACTORS;

RATTUS;

EID: 79953191859     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.87.81     Document Type: Review

References (41)

1. Lysaght, M.J. (2002) Maintenance dialysis population dynamics: current trends and long-term implication. J. Am. Soc. Nephrol. 13, S37-S40.
2. Nolan, C.R. (2005) Strategies for improving long-term survival in patients with ESRD. J. Am. Soc. Nephrol. 16, S120-S127.
3. Nakai, S., Masakane, I., Shigematsu, T., Hamano, T., Yamagata, K., Watanabe, Y., Itami, N., Ogata, S., Kimata, N., Shinoda, T., Syouji, T., Suzuki, K., Taniguchi, M., Tsuchida, K., Nakamoto, H., Nishi, S., Nishi, H., Hashimoto, S., Hasegawa, T., Hanafusa, N., Fujii, N., Marubayashi, S., Morita, O., Wakai, K., Wada, A., Iseki, K. and Tsubakihara, Y. (2008) An overview of regular dialysis treatment in Japan as 31 December 2007. Ther. Apher. Dial. 13, 457- 504.
4. Hostetter, T.H., Olson, J.L., Rennke, H.G., Venkatachalam, M.A. and Brenner, B.M. (1981) Hyperfiltration in Remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241, F85-F93.
5. Fogo, A.B. and Kon, V. (1997) Pathophysiology of progressive renal disease. In Immunologic Renal Diseases (eds. Neilson, E.G. and Couser, W.G.). Lippincott-Raven, Philadelphia/New York, pp. 683- 726.
6. Wada, Y., Morioka, T., Oyanagi-Tanaka, Y., Yao, J., Suzuki, Y., Gejyo, F., Arakawa, M. and Oite, T. (2002) Impairment of vascular regeneration proceeds progressive glomerulosclerosis in anti-Thy-1 glomerulonephritis. Kidney Int. 61, 432-443.
7. Morioka, T., Yao, J., Suzuki, Y. and Oite, T. (2004) The characterization of a specific Thy-1 molecular epitope expressed on rat mesangial cells. Kidney Int. 66, 2214-2223.
8. Oite, T., Saito, M., Suzuki, Y., Arii, T., Morioka, T. and Shimizu, F. (1996) A specific Thy-1 molecular epitope expressed on rat mesangial cells. Exp. Nephrol. 4, 350-360.
9. Nakayama, H., Oite, T., Kawachi, H., Morioka, T., Kobayashi, H., Orikasa, M., Arakawa, M. and Shimizu, F. (1998) Comparative nephritogenicity of two monoclonal antibodies of rat Thy-1.1 molecule. Nephron 78, 453-463.
10. Steinhausen, M., Zimmerhackl, B., Thederan, H., Dussel, R., Parekh, N., Esslomger, H.U., von Hagens, G., Komitowski, D. and Dallenbach, F.D. (1981) Intraglomerular microcirculation: measurements of single glomerular loop flow in rats. Kidney Int. 20, 230-239.
11. Hackbarth, H., Buttner, D., Jarck, D., Pothmann, M., Messow, C. and Gartner, K. (1983) Distribution of glomeruli in the renal cortex of Munich Wistar Fromter (MWF) rats. Ren. Physiol. 6, 63- 71.
12. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. and Nishimune, Y. (1997) 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313- 319.
13. Ikarashi, K., Li, B., Suwa, M., Kawamura, K., Morioka, T., Yao, J., Khan, F., Uchiyama, M. and Oite, T. (2005) Bone marrow cells contribute to regeneration of glomerular endothelial cells. Kidney Int. 67, 1925-1933.
14. Oyanagi-Tanaka, Y., Yao, J., Wada, Y., Morioka, T., Suzuki, Y., Gejyo, F., Arakawa, M. and Oite, T. (2001) Real time observation of hemodynamic changes in glomerular aneurysms induced by anti-Thy-1 antibody. Kidney Int. 59, 252-259.
15. Kawamura, K., Okada, S., Li, B., Suwa, M., Yao, J., Morioka, T., Gejyo, F. and Oite, T. (2006) Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis. Kidney Int. 69, 1792-1798.
16. Berne, R.M. and Levy, M.N. (2000) Hemodynamics. In Principles of Physiology. 3rd edition (eds. Berne, R.M. and Levy, M.N.). Mosby, St. Louis, pp. 227-236.
17. Yao, J., Morioka, T. and Oite, T. (2000) Requirement for PI3-kinase in PDGF-induced disruption of gap junctional intercellular communication and phosphorylation of connexin 43 in mesangial cells. Kidney Int. 31, 1915-1926.
18. 2+ wave. J. Am. Soc. Nephrol. 13, 2018-2026.
19. 2+ signaling and renin secretion in rat juxtaglomerular cells. Circ. Res. 93, 338-345.
20. Peti-Peterdi, J. (2006) Calcium wave of tubuloglomerular feedback. Am. J. Physiol. Renal Physiol. 291, F473-F480.
21. Peti-Peterdi, J. and Harris, R.C. (2010) Macula densa sensing and signaling mechanisms of renin release. J. Am. Soc. Nephrol. 21, 1093-1096.
22. Piao, H., Sato, A., Nozawa, Y., Sun, W., Morioka, T. and Oite, T. Effects of connexin-mimetic peptides on perfusion pressure in response to phenylephrine in isolated, perfused rat kidneys. Clin. Exp. Nephrol. (in press).
23. Wagner, C., Jobs, A., Schweda, F., Kurtz, L., Kurt, B., Lopez, M.L.S., Gomez, R.A., van Veen, T.A., de Wit, C. and Kurtz, A. (2010) Selective deletion of connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension. Kidney Int. 78, 762-768.
24. Oite, T. and Yao, J. (2009) Disturbance of glomerular hemodynamics: a risk factor determining progression of glomerular diseases? J. Nephrol. 22, 196-202.
25. Li, B., Morioka, T., Uchiyama, M. and Oite, T. (2006) Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int. 69, 323-330.
26. Brenner, B.M. (2002) Remission of renal disease: recounting the challenge, acquiring the goal. J. Clin. Invest. 110, 1753-1758.
27. Wilkes, B.M. (1987) Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism. Endocrinology 120, 1291-1298.
28. O'Brien, R.C., Cooper, M.E., Jerums, G. and Doyle, A.E. (1993) The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 42, 604-609.
29. Dechow, C., Morath, C., Peters, J., Lehrke, I., Waldherr, R., Haxsen, V., Ritz, E. and Wagner, J. (2001) Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. Am. J. Physiol. Renal Physiol. 281, F909-F919.
30. Ballermann, B.J., Skorecki, K.L. and Brenner, B.M. (2001) Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in rat. Am. J. Physiol. 247, F110-F116.
31. Mahmood, J., Khan, F., Okada, S., Kumagai, N., Morioka, T. and Oite, T. (2006) Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomeru-lonephritis. Kidney Int. 70, 1591-1598.
32. Harris, R.C., McKanna, J.A., Akai, Y., Jacobson, H.R., Dubois, R.N. and Breyer, M.D. (1994) Cyclooxigenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest. 94, 2504-2510.
33. Perazella, M.A. and Eras, J. (2000) Are selective COX-2 inhibitors nephrotoxic? Am. J. Kidney Dis. 35, 937-940.
34. Kitahara, M., Eitner, F., Ostendorf, T., Kunter, U., Janssen, U., Westenfeld, R., Matsui, K., Kerjaschki, D. and Floege, J. (2002) Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis. J. Am. Soc. Nephrol. 13, 1261-1270.
35. Williams, M.E. (2010) Diabetic CKD/ESRD 2010: a progress report? Semin. Dial. 23, 129-133.
36. Ruilope, L.M. (1997) Renoprotection and renin-angiotensin system blockade in diabetes mellitus. Am. J. Hypertens. 10, 325S-331S.
37. Lewis, E.J., Hunsicker, L.G., Clarke, W.R., Berl, T., Pohl, M.A., Lewis, J.B., Ritz, E., Atkins, R.C., Rohde, R. and Raz, I. for the Collaborative Study Group (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860.
38. Jacobsen, P., Andersen, S., Jensen, B.R. and Parving, H.H. (2003) Additive effect of ACE inhibition and angiotensin II receptor blocker in type I diabetic nephropathy. J. Am. Soc. Nephrol. 14, 992-999.
39. Li, B., Yao, J., Kawamura, K., Oyanagi-Tanaka, Y., Hoshiyama, M., Morioka, T., Gejyo, F., Uchiyama, M. and Oite, T. (2004) Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB. Kidney Int. 66, 1939-1948.
40. Kamal, F., Yanakieva-Georgieva, N., Piao, H., Morioka, T. and Oite, T. (2010) Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotoci-induced diabetic nephropathy through inhibition of calpain activity. Nephron, Exp. Nephrol. 115, e69-e79.
41. DeVriese, A.S., Stoenoiu, M.S., Elger, M., Devuyst, O., Vanholder, R., Kriz, W. and Lameire, N.H. (2001) Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide. Kidney Int. 60, 202-210.